Predictors of long-term outcome following percutaneous coronary intervention in patients with type 2 diabetes mellitus

Coronary Artery Disease

Volumn 17, Issue 2, 2006, Pages 131-138

  Thanyasiri, Panuratn ^a   Celermajer, David S ^a   Adams, Mark R ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Diabetes; Percutaneous coronary intervention; Restenosis

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33748524160     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200603000-00006     Document Type: Article

References (35)

1. Carrozza JP Jr, Kuntz RE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 1993; 118:344-349.
2. Holmes DR Jr, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984; 53:77C-81C.
3. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100:1872-1878.
4. Huynh T, Eisenberg MJ, Deligonul U, Tsang J, Okrainec K, Schechter D, et al. Coronary stenting in diabetic patients: results from the ROSETTA registry. Am Heart J 2001; 142:960-964.
5. Mathew V, Wilson SH, Barsness GW, Frye RL, Lennon R, Holmes DR. Comparative outcomes of percutaneous coronary interventions in diabetics vs non-diabetics with prior coronary artery bypass grafting. Eur Heart J 2002; 23:1456-1464.
6. Sobel BE. Acceleration of restenosis by diabetes: pathogenetic implications. Circulation 2001; 103:1185-1187.
7. Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T, et al. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997; 96:1454-1460.
8. Przewlocki T, Pieniazek P, Ryniewicz W, Kostkiewicz M, Olszowska M, Podolec P, et al. Long-term outcome of coronary balloon angioplasty in diabetic patients. Int J Cardiol 2000; 76:7-16.
9. Grundy S, Benjamin I, Burke G, Chait A, Eckel R, Howard B, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100:1134-1146.
10. Australian Institute of Health and Welfare. Australia's health 2002. Canberra: Australian Institute of Health and Welfare; 2002.
11. Ho KKL, Senerchia C, Rodriguez O, Chauhan MS, Kuntz RE. Predictors of angiographic restenosis after stenting. Circulation 1998; 98:362.
12. Ruderman NB, Haudenschild C. Diabetes as an atherogenic factor. Prog Cardiovasc Dis 1984; 26:373-412.
13. Adams MR, Nakagome A, Keech A, Robinson J, McCredie R, Bailey BP, et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation 1995; 92:2127-2134.
14. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51:606.
15. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990; 119:1262-1267.
16. Nakayama Y, Tsumura K, Yamashita N, Yoshimaru K, Hayashi T. Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty. Circulation 2000; 101:470-472.
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i:307-310.
18. Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998; 32:1866-1873.
19. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998; 32:584-589.
20. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al., Group TIS. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108:788-794.
21. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al., Investigators ES. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362:1093-1099.
22. Van Belle E, Abolmaali K, Bauters C, McFadden EP, Lablanche JM, Bertrand ME. Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. J Am Coll Cardiol 1999; 34:476-485.
23. Van Belle E, Ketelers R, Bauters C, Perie M, Abolmaali K, Richard F, et al. Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: a key determinant of survival in diabetics after coronary balloon angioplasty. Circulation 2001; 103:1218-1224.
24. Suselbeck T, Latsch A, Siri H, Gonska B, Poerner T, Pfleger S, et al. Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus. Am J Cardiol 2001; 88:243-247.
25. Asinger RW, Henry TD, Herzog CA, Paulsen PR, Kane RL. Clinical outcomes of PTCA in chronic renal failure: a case-control study for comorbid features and evaluation of dialysis dependence. J Invasive Cardiol 2001; 13:21-28.
26. Mattock MB, Barnes DJ, Viberti G, Keen H, Burt D, Hughes JM, et al. Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes 1998; 47:1786-1792.
27. Marso SP, Ellis SG, Tuzcu M, Whitlow PL, Franco I, Raymond RE, et al. The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics. J Am Coll Cardiol 1999; 33:1269-1277.
28. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325:836-842.
29. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340:319-323.
30. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352:837-853.
31. Hasdai D, Rizza RA, Grill DE, Scott CG, Garratt KN, Holmes DR Jr. Glycemic control and outcome of diabetic patients after successful percutaneous coronary revascularization. Am Heart J 2001; 141:117-123.
32. Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, et al. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 2004; 43:8-14.
33. Nakagomi A, Celermajer DS, Lumley T, Freedman SB. Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. Am J Cardiol 1996; 78:516-519.
34. Wilson SH, Celermajer DS, Nakagomi A, Wyndham RN, Janu MR, Ben Freedman S. Vascular risk factors correlate to the extent as well as the severity of coronary atherosclerosis. Coron Artery Dis 1999; 10:449-453.
35. Libby P, Aikawa M. New insights into plaque stabilisation by lipid lowering. Drugs 1998; 56:9-13.